PIGN encephalopathy: Characterizing the epileptology
Standard
PIGN encephalopathy: Characterizing the epileptology. / Bayat, Allan; de Valles-Ibáñez, Guillem; Pendziwiat, Manuela; Knaus, Alexej; Alt, Kerstin; Biamino, Elisa; Bley, Annette; Calvert, Sophie; Carney, Patrick; Caro-Llopis, Alfonso; Ceulemans, Berten; Cousin, Janice; Davis, Suzanne; des Portes, Vincent; Edery, Patrick; England, Eleina; Ferreira, Carlos; Freeman, Jeremy; Gener, Blanca; Gorce, Magali; Heron, Delphine; Hildebrand, Michael S; Jezela-Stanek, Aleksandra; Jouk, Pierre-Simon; Keren, Boris; Kloth, Katja; Kluger, Gerhard; Kuhn, Marius; Lemke, Johannes R; Li, Hong; Martinez, Francisco; Maxton, Caroline; Mefford, Heather C; Merla, Giuseppe; Mierzewska, Hanna; Muir, Alison; Monfort, Sandra; Nicolai, Joost; Norman, Jennifer; O'Grady, Gina; Oleksy, Barbara; Orellana, Carmen; Orec, Laura Elena; Peinhardt, Charlotte; Pronicka, Ewa; Rosello, Monica; Santos-Simarro, Fernando; Schwaibold, Eva Maria Christina; Stegmann, Alexander P A; Stumpel, Constance T; Szczepanik, Elzbieta; Terczyńska, Iwona; Thevenon, Julien; Tzschach, Andreas; Van Bogaert, Patrick; Vittorini, Roberta; Walsh, Sonja; Weckhuysen, Sarah; Weissman, Barbara; Wolfe, Lynne; Reymond, Alexandre; De Nittis, Pasquelena; Poduri, Annapurna; Olson, Heather; Striano, Pasquale; Lesca, Gaetan; Scheffer, Ingrid E; Møller, Rikke S; Sadleir, Lynette G.
in: EPILEPSIA, Jahrgang 63, Nr. 4, 04.2022, S. 974-991.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - PIGN encephalopathy: Characterizing the epileptology
AU - Bayat, Allan
AU - de Valles-Ibáñez, Guillem
AU - Pendziwiat, Manuela
AU - Knaus, Alexej
AU - Alt, Kerstin
AU - Biamino, Elisa
AU - Bley, Annette
AU - Calvert, Sophie
AU - Carney, Patrick
AU - Caro-Llopis, Alfonso
AU - Ceulemans, Berten
AU - Cousin, Janice
AU - Davis, Suzanne
AU - des Portes, Vincent
AU - Edery, Patrick
AU - England, Eleina
AU - Ferreira, Carlos
AU - Freeman, Jeremy
AU - Gener, Blanca
AU - Gorce, Magali
AU - Heron, Delphine
AU - Hildebrand, Michael S
AU - Jezela-Stanek, Aleksandra
AU - Jouk, Pierre-Simon
AU - Keren, Boris
AU - Kloth, Katja
AU - Kluger, Gerhard
AU - Kuhn, Marius
AU - Lemke, Johannes R
AU - Li, Hong
AU - Martinez, Francisco
AU - Maxton, Caroline
AU - Mefford, Heather C
AU - Merla, Giuseppe
AU - Mierzewska, Hanna
AU - Muir, Alison
AU - Monfort, Sandra
AU - Nicolai, Joost
AU - Norman, Jennifer
AU - O'Grady, Gina
AU - Oleksy, Barbara
AU - Orellana, Carmen
AU - Orec, Laura Elena
AU - Peinhardt, Charlotte
AU - Pronicka, Ewa
AU - Rosello, Monica
AU - Santos-Simarro, Fernando
AU - Schwaibold, Eva Maria Christina
AU - Stegmann, Alexander P A
AU - Stumpel, Constance T
AU - Szczepanik, Elzbieta
AU - Terczyńska, Iwona
AU - Thevenon, Julien
AU - Tzschach, Andreas
AU - Van Bogaert, Patrick
AU - Vittorini, Roberta
AU - Walsh, Sonja
AU - Weckhuysen, Sarah
AU - Weissman, Barbara
AU - Wolfe, Lynne
AU - Reymond, Alexandre
AU - De Nittis, Pasquelena
AU - Poduri, Annapurna
AU - Olson, Heather
AU - Striano, Pasquale
AU - Lesca, Gaetan
AU - Scheffer, Ingrid E
AU - Møller, Rikke S
AU - Sadleir, Lynette G
N1 - © 2022 International League Against Epilepsy.
PY - 2022/4
Y1 - 2022/4
N2 - OBJECTIVE: Epilepsy is common in patients with PIGN diseases due to biallelic variants; however, limited epilepsy phenotyping data have been reported. We describe the epileptology of PIGN encephalopathy.METHODS: We recruited patients with epilepsy due to biallelic PIGN variants and obtained clinical data regarding age at seizure onset/offset and semiology, development, medical history, examination, electroencephalogram, neuroimaging, and treatment. Seizure and epilepsy types were classified.RESULTS: Twenty six patients (13 female) from 26 families were identified, with mean age 7 years (range = 1 month to 21 years; three deceased). Abnormal development at seizure onset was present in 25 of 26. Developmental outcome was most frequently profound (14/26) or severe (11/26). Patients presented with focal motor (12/26), unknown onset motor (5/26), focal impaired awareness (1/26), absence (2/26), myoclonic (2/26), myoclonic-atonic (1/26), and generalized tonic-clonic (2/26) seizures. Twenty of 26 were classified as developmental and epileptic encephalopathy (DEE): 55% (11/20) focal DEE, 30% (6/20) generalized DEE, and 15% (3/20) combined DEE. Six had intellectual disability and epilepsy (ID+E): two generalized and four focal epilepsy. Mean age at seizure onset was 13 months (birth to 10 years), with a lower mean onset in DEE (7 months) compared with ID+E (33 months). Patients with DEE had drug-resistant epilepsy, compared to 4/6 ID+E patients, who were seizure-free. Hyperkinetic movement disorder occurred in 13 of 26 patients. Twenty-seven of 34 variants were novel. Variants were truncating (n = 7), intronic and predicted to affect splicing (n = 7), and missense or inframe indels (n = 20, of which 11 were predicted to affect splicing). Seven variants were recurrent, including p.Leu311Trp in 10 unrelated patients, nine with generalized seizures, accounting for nine of the 11 patients in this cohort with generalized seizures.SIGNIFICANCE: PIGN encephalopathy is a complex autosomal recessive disorder associated with a wide spectrum of epilepsy phenotypes, typically with substantial profound to severe developmental impairment.
AB - OBJECTIVE: Epilepsy is common in patients with PIGN diseases due to biallelic variants; however, limited epilepsy phenotyping data have been reported. We describe the epileptology of PIGN encephalopathy.METHODS: We recruited patients with epilepsy due to biallelic PIGN variants and obtained clinical data regarding age at seizure onset/offset and semiology, development, medical history, examination, electroencephalogram, neuroimaging, and treatment. Seizure and epilepsy types were classified.RESULTS: Twenty six patients (13 female) from 26 families were identified, with mean age 7 years (range = 1 month to 21 years; three deceased). Abnormal development at seizure onset was present in 25 of 26. Developmental outcome was most frequently profound (14/26) or severe (11/26). Patients presented with focal motor (12/26), unknown onset motor (5/26), focal impaired awareness (1/26), absence (2/26), myoclonic (2/26), myoclonic-atonic (1/26), and generalized tonic-clonic (2/26) seizures. Twenty of 26 were classified as developmental and epileptic encephalopathy (DEE): 55% (11/20) focal DEE, 30% (6/20) generalized DEE, and 15% (3/20) combined DEE. Six had intellectual disability and epilepsy (ID+E): two generalized and four focal epilepsy. Mean age at seizure onset was 13 months (birth to 10 years), with a lower mean onset in DEE (7 months) compared with ID+E (33 months). Patients with DEE had drug-resistant epilepsy, compared to 4/6 ID+E patients, who were seizure-free. Hyperkinetic movement disorder occurred in 13 of 26 patients. Twenty-seven of 34 variants were novel. Variants were truncating (n = 7), intronic and predicted to affect splicing (n = 7), and missense or inframe indels (n = 20, of which 11 were predicted to affect splicing). Seven variants were recurrent, including p.Leu311Trp in 10 unrelated patients, nine with generalized seizures, accounting for nine of the 11 patients in this cohort with generalized seizures.SIGNIFICANCE: PIGN encephalopathy is a complex autosomal recessive disorder associated with a wide spectrum of epilepsy phenotypes, typically with substantial profound to severe developmental impairment.
KW - Drug Resistant Epilepsy
KW - Electroencephalography
KW - Epilepsy/diagnostic imaging
KW - Female
KW - Humans
KW - Intellectual Disability/diagnostic imaging
KW - Phenotype
KW - Seizures/genetics
U2 - 10.1111/epi.17173
DO - 10.1111/epi.17173
M3 - SCORING: Journal article
C2 - 35179230
VL - 63
SP - 974
EP - 991
JO - EPILEPSIA
JF - EPILEPSIA
SN - 0013-9580
IS - 4
ER -